Expression of axl in lung adenocarcinoma and correlation with tumor progression
about
Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cellsAdvances in targeted therapies and new promising targets in esophageal cancerAXL kinase as a novel target for cancer therapyTargeting receptor tyrosine kinases in gastric cancerElevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.The Receptor Tyrosine Kinase AXL in Cancer ProgressionLigand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic ResponseBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingGas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma.GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.Effect of AXL on the epithelial-to-mesenchymal transition in non-small cell lung cancer.Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer.Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemiaOverexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.Axl-targeted cancer imaging with humanized antibody h173.Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft.Axl as a mediator of cellular growth and survivalThe novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.Axl phosphorylates Elmo scaffold proteins to promote Rac activation and cell invasion.Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinomaLow MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib.Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancerAXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.Axl receptor tyrosine kinase expression in breast cancerHypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
P2860
Q24658237-85F482E6-DF9F-47D7-ADC1-3C402598F89EQ26825957-FDDE5C9E-0922-491A-AD1C-A79C2051FB57Q26863442-8AB3C741-E124-45A1-9063-04F059E206A8Q27013050-3D9391CB-4E4E-4FC3-B148-A77B7F3C1244Q27853191-BD3EEE34-A042-43BB-A725-9D2494EC77FAQ27853383-365A9AF6-E63E-45AE-A649-D2792210B3D6Q28068756-88AD12C6-3A20-44B6-8BBE-E7AD7C869EDCQ28072503-2F51ED4F-3CA3-407C-91C8-F7B24E566DFEQ28288148-08AA6310-FDBF-4A16-B70C-114589FD415EQ28389391-812D9F47-5F2B-46F7-8428-34ADD7767FB8Q28395095-0ED116FC-A41A-4D5A-AEA7-BC63259CB2CFQ33514834-46C7527D-BFA1-4B2D-BE2F-F2818A984AF9Q33591281-1B786CA5-FFD2-4D80-84C8-3EC0DC08A643Q33622570-08EDAB09-5F24-43AF-AA35-B90CE09FE454Q33847457-12B097D9-6FC9-486C-8DA6-BA8F59B70B80Q33874421-36D8101A-F24E-480B-A888-6DD0D97E7DC1Q33891230-C6848147-B34E-472B-BA13-6AD3E92BAED3Q33916284-E03E10DE-C1B6-4890-8588-F995DCDD70A3Q34022457-5E1E9229-B68C-4C59-9B30-6818F617DA90Q34080843-1915A373-8016-44E7-B503-5E73BA766AA0Q34170756-86B8D39E-701D-458C-8023-9ADF29E96AB2Q34283197-E2900B51-B0AD-41AC-950B-AD060B7514DCQ34473426-10296D16-2AAE-473F-87FE-F920CB3D7795Q34619118-B504CF22-9C49-4DCA-9877-BD6A4B809F81Q34667753-9F2623FE-382A-47F7-B174-C4091F74CF14Q34794927-A7EA5BBE-2160-45E6-9AC1-46A361BB9DE6Q34968578-5CE338B7-7BD9-4B52-9BC0-FF96B3EEEB62Q35111750-F9C0F8DA-BC60-43A2-BC23-0D80A45D1144Q35125173-71FF7CDA-F6CB-4440-A605-5F54EE526BA3Q35486521-BDC0B0AA-C9BF-4B72-855A-C865C5DD2E20Q35596369-77C2E88B-1AEF-4E6C-8986-5CDFC23B1F9CQ35726091-4F18D41B-1652-4AAD-893B-305EE92F9F80Q35775881-013F7D43-B4C4-4449-AE66-F529C68470A9Q35832327-A8AC6548-F50C-4A22-9A62-7510628181F4Q35832938-F63272BA-C1DB-41F4-9D78-B22634EFAF5DQ35843071-36E4A213-7A54-4F23-9E30-D0F7E156A200Q35899490-C05EA425-1516-4E77-93A1-C0586F438081Q35927501-3902BB45-5AD7-4CF9-AA5B-EAC2A985368BQ35996780-89B3DB9C-52B5-486A-84ED-09EF05E9C4A4Q36044487-09F8A01E-4F00-4381-9ACE-A446FECCD5B4
P2860
Expression of axl in lung adenocarcinoma and correlation with tumor progression
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@ast
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@en
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@nl
type
label
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@ast
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@en
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@nl
prefLabel
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@ast
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@en
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@nl
P2093
P2860
P356
P1433
P1476
Expression of axl in lung adenocarcinoma and correlation with tumor progression
@en
P2093
Cheng-Wen Wu
Chiung-Ya Lai
Herng-Sheng Lee
Shine-Gwo Shiah
Yi-Shing Shieh
Yi-Wen Chu
Yu-Rung Kao
P2860
P304
P356
10.1593/NEO.05640
P577
2005-12-01T00:00:00Z